Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001803:Blood Transfusion; D003524:Cyclosporins / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007109:Immunity; D007165:Immunosuppression Therapy; D007518:Isoantibodies / Q000276:immunology*; D007676:Kidney Failure, Chronic / Q000628:therapy; D016030:Kidney Transplantation; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008875:Middle Aged; D014019:Tissue Donors
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D006680:HLA Antigens; D007518:Isoantibodies